To characterize the extraneuronal accumulation of catecholamines (CA) in the media of rabbit aorta pieces of isolated media were incubated with 3H-CA (norepinephrine, isoproterenol or normetanephrine) plus 14C-sorbitol (to estimate the extracellular space) for varying periods at 37 or 0 °C. The 3H-CA accumulation was 1.3 ml/g at 0 °C and 2.2 ml/g at 37 °C. The sorbitol space was 0.6 ml/g at both temperatures. CA accumulation at 0 and 37 °C is significantly different from each other and from sorbitol accumulation. Corticosterone and phenoxybenzamine inhibit the temperature-sensitive component of CA accumulation. Accumulation of norepinephrine at 0 ° C is unaffected by corticosterone, phenoxybenzamine or oxytetracycline. The initial rate of NE accumulation at 37 °C, from steady state accumulation at 0 °C, and the initial rate of accumulation at 0 °C were linear functions of NE concentration between 10-7 and 10-2 M. Based on differences in sensitivity to corticosterone and temperature, we conclude that CA accumulation at 0 ° C is different from the accumulation at 37 °C.

Keywords:
Catecholamine, Norepinephrine, Accumulation, Vascular smooth muscle, Temperature, Corticosterone, Sorbitol, Oxytetracycline, Pargyline, U-0521
This content is only available via PDF.
© 1983 S. Karger AG, Basel
1983
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.